How do we support large cohort studies over many years in terms of retention of subjects, manpower, funding, and appropriate outcome tools?
Utilization of well characterized cohort studies and clinical trials to conduct ancillary scientific studies on pathophysiology, responses to treatment, and identify new ways to predict and treat disease. Restore the Ancillary Studies mechanism. Improved biobanks and data sharing platforms are needed. Facilitate public-private partnerships.
How best can NHLBI observational cohorts be utilized to study observational T4 Implementation Research among both general and vulnerable US populations?